The necessity of influenza vaccination in children

Pediatric Annals

Volumn 39, Issue 8, 2010, Pages 490-496

  Libster, Romina ^a,b   Edwards, Kathryn M ^b,c  

^a Ciudad Autónoma de Buenos Aires   (Argentina)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ATTITUDE TO HEALTH; CHILD; COST OF ILLNESS; DRUG EFFECTS; HUMAN; INFANT; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PROCEDURES; UNITED STATES; VACCINATION;

CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; UNITED STATES; VACCINATION;

EID: 77956535609     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20100726-07     Document Type: Review

References (32)

1. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4):232-239.
2. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med. 2000;342(4):225-231.
3. Iwane MK, Edwards KM, Szilagyi PG, et al. New Vaccine Surveillance Network. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics. 2004;113(6):1758-1764.
4. Poehling KA, Edwards KM, Weinberg GA, et al. New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355(1):31-40.
5. Montes M, Vicente D, Pérez-Yarza EG, Cilla G, Pérez- Trallero E. Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: A 3-year study (July 2001-June 2004). Vaccine. 2005;23(34):4302-4306.
6. Chiu SS, Chan KH, Chen H, et al. Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis. 2009;49(7):1016-1021.
7. Bhat N, Wright JG, Broder KR, et al.; Influenza Special Investigations Team. Influenza- associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005;353(24):2559-2567.
8. Centers for Disease Control and Prevention (CDC). Flu Activity & Surveillance. Available online at: www.cdc.gov/flu/weekly/fluactivity. htm. Accessed July 17, 2010.
9. Neuzil KM, Hohlbein C, Zhu Y. Illness among schoolchildren during influenza season: Effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med. 2002;156(10):986-991.
10. Centers for Disease Control and Prevention. Influenza vaccination coverage among children and adults - United States, 2008-09 influenza season. MMWR Morb Mortal Wkly Rep. 2009;58(39):1091-1095.
11. Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis. 1994;169(1):68-76.
12. Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: The pediatric experience. Pediatr Infect Dis J. 2001;20(8):733-740.
13. Manzoli L, Schioppa F, Boccia A, Villari P. The efficacy of influenza vaccine for healthy children: A meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J. 2007;26(2):97-106.
14. Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: A summary for the new era of routine vaccination. Pediatr Infect Dis J. 2004;23(3):189-197.
15. Halasa NB, Gerber MA, Chen Q, Wright PF, Edwards KM.Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis. 2008;197(10):1448-1454.
16. Walter EB, Englund JA, Blatter M, Nyberg J, Ruben FL, Decker MD; GRC27 Study Team. Trivalent inactivated influenza virus vaccine given to 2-month-old children: An off-season pilot study. Pediatr Infect Dis J. 2009;28(12):1099- 1104.
17. France EK, Glanz JM, Xu S, et al. Safety of the trivalent inactivated influenza vaccine among children: A population-based study. Arch Pediatr Adolesc Med. 2004;158(11):1031-1036.
18. McMahon AW, Iskander J, Haber P, Chang S, Woo EJ, Braun MM, Ball R. Adverse events after inactivated influenza vaccination among children less than 2 years of age: Analysis of reports from the vaccine adverse event reporting system, 1990-2003. Pediatrics. 2005;115(2):453-460.
19. Rosenberg M, Sparks R, McMahon A, Iskander J, Campbell JD, Edwards KM. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age. Vaccine. 2009;27(32):4278-4283.
20. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, coldadapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med. 1998;338(20):1405-1412.
21. Belshe RB, Edwards KM, Vesikari T, et al.; CAIV-T Comparative Efficacy Study Group. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med. 2007;356(7):685-696.
22. Tam JS, Capeding MR, Lum LC, et al; Pan-Asian CAIV-T Pediatric Efficacy Trial Network. Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J. 2007;26(7):619-628.
23. Belshe RB, Ambrose CS, Yi T. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Vaccine. 2008;26 Suppl 4:D10-D16.
24. Fleming DM, Crovari P, Wahn U, et al.; CAIVT Asthma Study Group. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J. 2006;25(10):860-869.
25. Piedra PA, Gaglani MJ, Riggs M, et al. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics. 2005;116(3):e397-e407.
26. Centers for Disease Control and Prevention. Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009;58(15):400-402.
27. Libster R, Bugna J, Coviello S, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2010;362(1):45-55.
28. Jain S, Kamimoto L, Bramley AM, et al; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361(20):1935-1944.
29. Update on influenza A (H1N1) 2009 monovalent vaccines. MMWR Morb Mortal Wkly Rep. 2009;58(39):1100-1101.
30. Kuehn BM. CDC names H1N1 vaccine priority groups. JAMA. 2009;302(11):1157-1158.
31. Nolan T, McVernon J, Skeljo M, et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trial. JAMA. 2010;303(1):37-46.
32. CDC. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, Oct. 1-Nov. 24, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(48):1351-1356.